You will not be allowed to compare more than 4 products at a time
View comparePAIDINIL 30 TABLETS
PAIDINIL 30 TABLETS
Regular price
€18,40 EUR
Sale price
€18,40 EUR
Regular price
€21,00 EUR
Unit price
per
Tax included.
SKU
983450192In stock
Vendor
EPITECH GROUP SpADelivery time: 48/72 hours
Free Shipping: Orders over €70
This product page, including its Product Information Leaflet, has been automatically translated.
Description
paidinil
Description
Food for special medical purposes, strawberry flavor.
Tissue neuroinflammation is a biological process that, in pediatric age, due to neuro-immune immaturity, can become uncontrolled, altering the normal development of tissues, including the peripheral and/or central nervous system. The clinical manifestations of neuroinflammation in pediatric age depend on the affected body district and predispose the subject to recurrent respiratory syndromes and dermo-epidermal manifestations (dermatitis of various etiologies).
In such conditions, the body, subjected to recurrent neuroinflammatory phenomena caused by exposure to multiple factors (viruses, bacteria, allergens, stress situations, hormones, etc.), tends to deplete its capacity for endogenous palmitoylethanolamide synthesis, a natural substance also present in breast milk, with marked protective properties that promote the function of the nervous and immune systems.
Palmitoylethanolamide, present in paidinil chewable tablets in ultra-micronized form (PEA-um), has been shown to control neuroinflammation of various tissues, including respiratory and muco-cutaneous tissues.
It is to be used under medical supervision, for dietary management, in situations of uncontrolled neuroinflammation, in pediatric patients over 7 years of age with:
1. Recurrent respiratory syndromes:
- Recurrent respiratory infections
- Allergic-inflammatory states
2. Dermo-epidermal manifestations (dermatitis of various etiologies).
Gluten-free and lactose-free.
How to use
It must be used under medical supervision by pediatric patients over 7 years of age. As a general guideline, it is recommended to take 1 chewable tablet 1-2 times a day for cycles of 30-60 days, preferably after meals, according to medical advice. The tablet should be chewed to facilitate swallowing; it can also be crushed and mixed with semi-liquid foods (creams, purees, smoothies, yogurt, etc.).
Warnings
Use under medical supervision. The product cannot be the sole source of nourishment. Keep out of reach of children under 3 years of age. Use is not recommended for children under 7 years of age or with swallowing difficulties.
Format
30 chewable tablets.
Code. 8082
Food for special medical purposes, strawberry flavor.
Tissue neuroinflammation is a biological process that, in pediatric age, due to neuro-immune immaturity, can become uncontrolled, altering the normal development of tissues, including the peripheral and/or central nervous system. The clinical manifestations of neuroinflammation in pediatric age depend on the affected body district and predispose the subject to recurrent respiratory syndromes and dermo-epidermal manifestations (dermatitis of various etiologies).
In such conditions, the body, subjected to recurrent neuroinflammatory phenomena caused by exposure to multiple factors (viruses, bacteria, allergens, stress situations, hormones, etc.), tends to deplete its capacity for endogenous palmitoylethanolamide synthesis, a natural substance also present in breast milk, with marked protective properties that promote the function of the nervous and immune systems.
Palmitoylethanolamide, present in paidinil chewable tablets in ultra-micronized form (PEA-um), has been shown to control neuroinflammation of various tissues, including respiratory and muco-cutaneous tissues.
It is to be used under medical supervision, for dietary management, in situations of uncontrolled neuroinflammation, in pediatric patients over 7 years of age with:
1. Recurrent respiratory syndromes:
- Recurrent respiratory infections
- Allergic-inflammatory states
2. Dermo-epidermal manifestations (dermatitis of various etiologies).
Gluten-free and lactose-free.
How to use
It must be used under medical supervision by pediatric patients over 7 years of age. As a general guideline, it is recommended to take 1 chewable tablet 1-2 times a day for cycles of 30-60 days, preferably after meals, according to medical advice. The tablet should be chewed to facilitate swallowing; it can also be crushed and mixed with semi-liquid foods (creams, purees, smoothies, yogurt, etc.).
Warnings
Use under medical supervision. The product cannot be the sole source of nourishment. Keep out of reach of children under 3 years of age. Use is not recommended for children under 7 years of age or with swallowing difficulties.
Format
30 chewable tablets.
Code. 8082